Rosellina M. Mancina
Goeteborg, O, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 80 publications
Fatty Pancreas and Risk of Type 2 Diabetes, Chronic Kidney Disease and Cardiovascular Events: Evidence From a Population-Based Cohort.
Journal: United European gastroenterology journal
Published: May 22, 2026
Glucocorticoid exposure during nutrient deprivation impairs recovery in postmitotic myotubes.
Journal: Scientific reports
Published: January 08, 2026
MTARC1 p.A165 ablation reduces hepatocellular carcinoma aggressiveness in vitro and in vivo.
Journal: Clinical and molecular hepatology
Published: December 06, 2025
Carriage of rare APOB variants predisposes to severe steatotic liver disease and hepatocellular carcinoma.
Journal: The Journal of clinical investigation
Published: October 28, 2025
Di-Lineage Hepatic Spheroids From Human Donors Capture Steatotic Liver Disease.
Journal: Cellular and molecular gastroenterology and hepatology
Published: August 18, 2025
Correspondence to editorial on "Downregulation of the MARC1 p.A165 risk allele reduces hepatocyte lipid content by increasing beta-oxidation".
Journal: Clinical and molecular hepatology
Published: July 11, 2025
Editorial: Time to Genotype-Genetic Risk and Prognosis in Steatotic Liver Disease.
Journal: Alimentary pharmacology & therapeutics
Published: June 30, 2025
Decreased degree of adipocyte differentiation in visceral adipose tissue contributes to metabolic dysfunction-associated steatotic liver disease.
Journal: Nature communications
Published: March 03, 2025
Genome-wide interaction study with body mass index identifies CYP7A1 and GIPR as genetic modulators of metabolic dysfunction-associated steatotic liver disease.
Journal: Clinical and molecular hepatology
Published: February 26, 2025
Publisher Correction: Partitioned polygenic risk scores identify distinct types of metabolic dysfunction-associated steatotic liver disease.
Journal: Nature medicine
Published: January 17, 2025
Human genetics of steatotic liver disease: insights into insulin resistance and lipid metabolism.
Journal: Nature metabolism
Published: September 04, 2024
TM6SF2 and PNPLA3: A potential dynamic duo?: Editorial on "TM6SF2 E167K variant decreases PNPLA3-mediated PUFA transfer to promote hepatic steatosis and injury in MASLD".
Journal: Clinical and molecular hepatology
Published: August 22, 2024
Last Updated: 09/26/2026